Adeno-associated virus (AAV) mediates gene targeting in humans by providing exogenous DNA for allelic replacement through homologous recombination. In comparison to other methods of DNA delivery or alternative DNA substrates, AAV gene targeting is reported to be very efficient, perhaps due to its single-stranded DNA genome, the inverted terminal repeats (ITRs), and/or the consequence of induced cellular signals on infection or uncoating. These viral attributes were investigated in the presence and absence of an I-Sce endonucleaseinduced double-strand break (DSB) within a chromosomal defective reporter in human embryonic kidney cells. Gene correction was evaluated using self-complementary (sc) AAV, which forms a duplexed DNA molecule and results in earlier and robust transgene expression compared with conventional single-strand (ss) AAV genomes. An scAAV repair substrate was modestly enhanced for reporter correction showing no dependency on ssAAV genomes for this process. The AAV ITR sequences were also investigated in a plasmid repair context. No correction was noted in the absence of a DSB, however, a modest inhibitory effect correlated with the increasing presence of ITR sequences. Similarly, signaling cascades stimulated upon recombinant AAV transduction had no effect on plasmid-mediated DSB repair. Noteworthy, was the 20-fold additional enhancement in reporter correction using scAAV vectors, over ss versions, to deliver both the repair substrate and the endonuclease. In this case, homologous recombination repaired the defective reporter in 4% of cells without any selection. This report provides novel insights regarding the recombination substrates used by AAV vectors in promoting homologous recombination and points to the initial steps in vector optimization that could facilitate their use in gene correction of genetic disorders.
Introduction
Gene targeting is the process in which exogenously delivered nucleic acids are used to modify a partially homologous target by homologous recombination. [1] [2] [3] This ability is largely conserved across kingdoms, and early work in mouse embryonic stem cells showed gene knockout technology using plasmid DNA for repair. 1, 4 The transition of this powerful approach to human genetic correction for therapeutic applications, however, is limited by the relative inefficiency of the repair process (about one in a million) in addition to challenges for effective DNA delivery.
Following the cloning of the adeno-associated virus (AAV) genome and subsequent applications for therapeutic gene addition in humans, 5 the recombinant virus was noted to be enhanced several orders of magnitude for gene targeting, compared with plasmid or alternate virus-mediated recombination. 1, 6, 7 AAV is a single-strand (ss) DNA dependovirus of the family, Parvoviridae. The 4.7 kb genome is flanked by 145 nucleotide inverted terminal repeats (ITRs). In the absence of selection, AAV-induced homologous recombination levels have been as high as 1%. 8 Several reports have characterized this process and note that the efficiency of the event depends on several factors including (1) type of target mutation, (2) length of repair homology, (3) position of the site of repair on the AAV genome with respect to the viral ITRs, (4) cell cycle and (5) chromosomal context. [9] [10] [11] [12] AAV is efficient for gene targeting perhaps due to nuclear localization of a high number of genomes, the recombinogenic ITRs and/or the ss nature of the AAV vector template. 9 Consistent with the third hypothesis was the observation that duplexed AAV genomes, from smaller than wild-type packaging cassettes, when mixed with ss genomes, did not contribute significantly to gene targeting. 9 However, the importance of an ss repair substrate is logical, as no helicase would be necessary for replication protein A binding, followed by heteroduplex formation, strand exchange or synthesisdependent strand annealing, and subsequent opposite strand repair.
Although ss genome dependency for AAV gene targeting represents an attractive hypothesis, it remains at odds with the observations that both increased time and transduced genomes enhance this process. 8, 13 In human cell cultures, ssAAV2 initiates transgene synthesis soon after infection (green fluorescent protein (Gfp) fluorescence is detectable as early as 6 h), confirming that at least some AAV genomes are not ss (data not shown (DNS)). In fact, the duplexed genomes are a natural part of AAV transduction and are generated in two ways: (1) synthesis of the complementary strand using ITR priming or (2) by opposite polarity genome annealing (both + and À are packaged at similar efficiencies). 14, 15 Although the chosen mechanism appears cell line and tissue specific, it is also a function of the multiplicity of infection. At higher multiplicity of infections, AAV genomes likely anneal, yet may still undergo second-strand synthesis, and both processes would increase over time shifting the equilibrium away from ss and toward duplexed genomes. 15 These considerations suggest that all of the above-mentioned AAV gene targeting experiments most likely produced a significant mixture of AAV vector DNA templates (that is, ss or duplexed) making it virtually impossible to assign targeting efficiency to a particular substrate. 8, 12 More importantly, circular DNA substrates unrelated to AAV virion delivery, or the presence of the ITRs, showed nearly identical results from a direct comparison of ss and duplexed DNA for mammalian gene targeting. 16 Similar to AAV second-strand synthesis, this report also notes synthesis of a complementary strand for the M13 produced ss circular DNA even in the absence of a mammalian replication origin. 16 
Results
To investigate whether ss or duplexed AAV genomes are preferred in gene targeting, we used our previously described self-complementary (sc) context. 17 Such particles harbor a single DNA molecule with a hinge (mutant ITR) at one end and near-perfect complementarity thereon. 17 Theoretically, these molecules snap back on themselves forming duplexed DNA. Physiologically, both in cell lines and in vivo, scAAV results in earlier and dramatically enhanced transgene synthesis compared with conventional ssAAV. 17, 18 Using a human embryonic kidney cell line containing a chromosome defective gfp reporter harboring a 35 bp insertion, 19 we performed a head to head comparison of ssAAV2 versus scAAV2 repair substrates (Figure 1 ). The promoter-less, truncated gfp repair homology of ssAAV2-gfp repair 13 was cloned into an scAAV2 plasmid 17 and transduction by either virus alone does not result in GFP synthesis in unmodified human embryonic kidney cells. 13 Production, characterization and quantitation of all recombinant AAV vectors were as described. 20 Southern blot analysis of both the ss and scAAV2-gfp repair genomes was used as an additional control ( Figure 1a) . The purity of the respective viral genomes was nearly 100%.
Given the results of others 13 and preliminary experiments (DNS), we chose a ratio of 10 000 genomecontaining particles (gcps) per cell. Gfp+ cells after transduction by either virus were scarce, regardless of the nature of the repair genome ( Figure 2b ). However, a modest increase was noted for scAAV over ssAAV, with targeting values of 0.004 and 0.002%, respectively. From these experiments, Gfp+ cells were isolated by fluorescence-activated cells sorting and sequence analysis of ten clones from either group (ss or sc) suggested error-free homologous recombination as the mechanism of repair (DNS).
Many reports using various technologies agree that a local double-strand break (DSB) increases targeted gene correction. [21] [22] [23] [24] [25] [26] Thus, due to the inadequate targeting efficiency of AAV for human therapy applications, we investigated the enhancement of this process by a DSB generated by a yeast-derived endonuclease, I-SceI (Sce). Conveniently, the 35 bp insert of the defective gfp cell line harbors the Sce recognition sequence and cleavage at this site results in 4 nt 3 0 overhangs. 19 Co-transduction of an ssAAV2-CMV-Sce, 13 along with ssAAV2-gfp repair (10 000 gcp per cell of each virus), resulted in an approximate 100-fold increase in the amount of cells positive for Gfp (Figure 1b The defective gfp 293 cell line was infected with either ss or sc AAV2-gfp repair (R) at a gcp/cell ratio of 10 000. Simultaneously, cells were also transduced by another vector, either ssAAV2-factor9 repair (no double-strand break (no ÀDSB)) or ssAAV2-Sce (+DSB) at 10 000 gcp per cell. Gfp+ cells were quantitated by flow cytometry at the indicated times.
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In nearly all cases, transduction by scAAV results in rapid and robust transgene expression when compared with the ss equivalent. 17 Therefore, we evaluated this observation for Sce by packaging it in the sc format. 17 Genome purity of the ss and scAAV2-Sce variants was near 100% as determined by Southern blot analysis (Figure 2a ). Gfp+ cells were quantitated following co-transduction of scAAV2-gfp repair and either ss or scAAV2-Sce (10 000 gcp per cell of each virus). Delivery of Sce in the sc context resulted in a therapeutic level of reporter activity (3-4%) that was increased 2000-fold over ssAAV2-gfp repair gene targeting in the absence of an induced break (Figure 2b) . The dramatic effect of scAAV2-Sce compared with the ss version correlated to increased Sce abundance (Figure 2c ). In addition, the targeting efficiency likely underrepresents the actual value, as it is not normalized to AAV2 co-transduction. In other experiments using the same capsid, cells and gcp/cell ratio, this value was approximated at 80-85% (DNS).
Because the ss nature of the AAV genome did not enhance repair, compared with the duplexed version, we also investigated the role of the ITRs in this process. To determine if the AAV ITR sequence stimulates DSB repair, we cloned the identical gfp repair homology into plasmid constructs containing no ITR, one ITR 27 or between two ITRs. 28 These substrates were compared for their ability to repair the defective gfp cell line containing the 35 bp insertion. Co-transfection of either repair plasmid, along with a plasmid expressing Sce 13 at a ratio of 4:1, respectively, showed a slight decrease in Gfp+ cells inversely correlated with increasing number of ITRs present (Figure 3) . Although the double-strand plasmid context of the ITRs is different from that of viral genomes, these data suggest that the ITRs solely do not stimulate targeted DSB repair of the host chromosome, despite the likelihood of being processed to a DSB by host repair enzymes as reported. 29 This result is perhaps consistent with a report describing no contribution of AAV ITRs to chromosome integration (in a double-strand plasmid context) in vivo.
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As the ss nature of the AAV genome appears not required for efficient AAV targeting, nor do the isolated ITR sequences placed next to repair homology, it was hypothesized that AAV-induced signaling cascades originating from particle binding, trafficking and/or uncoating influence the efficiency of the event. For example, AAV transduction induces a DNA damage response that arrests cells at the G2/M checkpoint 31 and results in the altered expression of cell-cycle regulators including p21WAF and several cyclin proteins. 32 In addition, empty AAV capsids elicited similar changes in the expression of these regulators, suggesting that signaling cascades, initiated from binding or entry, altered regulation as these particles do not accumulate in the nucleus and do not contain an AAV genome (DNS). 32 Therefore, the ability of a plasmid, containing two ITR sequences flanking the gfp repair homology mentioned above, to repair a chromosomal DSB was investigated during the infection of an ssAAV vector that has no target or repair homology. For these experiments, Gfp+ cells were quantitated 3 days after a co-transfection then transduction scheme, or vice versa. The co-transfection event used both the ITR repair plasmid and the CMV-SceI expression plasmid given either 12 h Targeting by scAAV M Hirsch et al before or after ssAAV2-TTR-F9 infection at the indicated multiplicity of infections ( Figure 4) . In either regimen, no significant effect of plasmid-mediated DSB correction of the host chromosome was observed upon nonhomologous AAV infection at different gcp/cell ratios.
Discussion
Herein, we tested a standing hypothesis that the ss nature of the AAV genome is necessary for AAV gene correction. 9 This assertion is sensible as an ssAAV genome could directly compete for annealing at its chromosomal target site without requiring the assistance of a helicase for strand unwinding (as would be necessary for duplexed repair substrates). However, the results herein show that scAAV genomes also mediate gene correction, and at a level slightly increased compared with the ss equivalent. Although significant, the twofold increase in targeting efficiency of sc over ssAAV was modest, and could simply be explained by the fact that the sc genomes actually have two copies of repair homology in opposite polarities on a single molecule. 17 Another possible explanation for scAAV genomes serving as templates for homologous recombination is that in addition to the mechanisms of chromosomal repair induced by ss genomes, such as gene conversion, duplexed genomes can also undergo double crossover events. Observations of increased stability of the scAAV genomes could also result in increased targeting efficiencies. 18 Perhaps more promising from a therapeutic standpoint is the ability to increase AAV targeting efficiencies using a local DSB 13 ( Figure 1 ). As the Sce site is not found in the human genome, much effort is focused on the generation of designer endonucleases (that is Zn-finger endonucleases, homing endonucleases and so on) that can be tailored for recognition and cleavage at a specific chromosomal site. 19, 33, 34 Although the efficiencies of these enzymes for target cleavage varies, gene correction values have been reported near 20%. 34 However, concerns remain as to the toxicity of designer endonucleases as DSBs can induce apoptosis and, depending on the binding efficiency of the endonuclease, off-target cutting may occur. Therefore, transient expression of these molecules is preferred, as well as obligate nuclease heterodimerization domains. 35, 36 As such, the direct application of this technology to in vivo applications is unlikely. Thus, ex vivo manipulations of human stem cells represents a more attractive approach, especially given the ability to direct their differentiation. 37 Therefore, it seems possible to repopulate an individual with their own cells that have been genetically modified with the greatest barrier being selection of the relatively rare event or achieving a high enough correction efficiency to avoid the difficulties and problems associated with clonal isolation and outgrowth. For this purpose, use of AAV packaged with an sc genome may be preferable as the capsid can be tailored for transduction of many cell types and unwanted vector genome integration is inherently minimal and can be further reduced.
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Materials and methods
Maintenance of cells
A human embryonic kidney cell line, having a defective gfp reporter integrated into the chromosome, was used for all experiments, unless indicated, and was described previously. 19 All cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum and 1 Â Penn/Strep (DMEM+; Sigma, St Louis, MO, USA). Cells were maintained at 37 1C in a 5% CO 2 humidified incubator.
AAV production and characterization
All vectors used in this study were produced using a triple transfection protocol followed by CsCl gradient centrifugation and dialysis in 1 Â phosphate-buffered saline solution as previously described. 20 The ssAAV production plasmids for CMV-Sce and the gfpR homology were also previously described. 13 To create the sc AAV versions of these plasmids, we cloned the identical sequence elements (CMV-Sce or gfpR) into the pHpa-Trs-SK plasmid previously described. 17 In all cases, these recombinant AAV genomes were packaged in the AAV serotype 2 capsids. Virus titer was determined by Southern dot blot and Southern alkaline gel electrophoresis as previously described. A total 50 000 293 cells were seeded in a 24-well plate 24 h before transduction. The next day, the indicated amount of virus particles was diluted in 50 ml of DMEM+ before well addition. At the indicated time point (usually 72 h), cells were harvested by gentle aspiration, washed in phosphate-buffered saline and resuspended in phosphate-buffered saline for immediate flow cytometric analysis. In the experiments described herein, the co-transduction efficiency was not explicitly determined, thus the experimental results were not corrected for co-transduction and likely underrepresent the actual values. All experiments were performed in triplicate on at least three different days, and the results were presented as the averages of the experimental data.
Western blot
Sample preparation for western analysis followed standard techniques. 20 An unlabeled primary antibody against the N-terminal HA-Tag on Sce was used as recommended by the manufacturer (Abcam, Cambridge, MA, USA). An anti-rabbit IgG antibody conjugated to horse-radish peroxidase was used as the secondary antibody and blots were developed using a chemiluminescent substrate kit as recommended by the manufacturer (Pierce, Rockford, IL, USA).
Analysis of Gfp+ cells
Gfp+ cells were visualized by fluorescent microscopy and quantitated by flow cytometry at the indicated time points. A minimum of 100 000 similar sized/shaped single cells were counted, for each replicate, at the indicated times at an event per second rate of 1500-2000. The Gfp+ gate was designed such that untreated cells did not give a single Gfp+ event beyond a million counted cells. It was also positioned away from false, or transitioning, Gfp+ cells to obtain no false positives. Gfp+ cells were isolated by fluorescence-activated cell sorting for single cells and the corrected gfp sequence of 10 Gfp+ clones was confirmed by direct sequencing (DNS, primer sequences available upon request).
Plasmid transfections
In these experiments (performed on cells in a 24-well format), 1 mg of plasmid DNA was diluted in DMEM without supplements, vortexed in the presence of PEI and the mixture was added to the well 10 min later. Under these conditions, transfection of an equivalent amount of a CMV-Gfp expression plasmid results in 80% Gfp+ cells.
